Year All2024202320222021202020192018201720162015 September 30, 2015 FierceBiotech Names Revolution Medicines as a “Fierce 15” Biotech Company of 2015 June 1, 2015 Rationally Designed Antifungal Compounds that Evade Resistance Reported in Nature Chemical Biology by Scientific Founder of REVOLUTION Medicines April 9, 2015 REVOLUTION Medicines Appoints Pharmaceutical Commercial Executive Elizabeth McKee Anderson to Board of Directors March 12, 2015 Major Advances in Synthetic Chemistry Reported in Science by Founding Scientist of REVOLUTION Medicines March 5, 2015 REVOLUTION Medicines Expands Executive Leadership Team February 4, 2015 Third Rock Ventures Launches REVOLUTION Medicines with $45 Million Series A to Redesign Evolution’s Products to Treat Serious Diseases